Free Access
Issue
J Extra Corpor Technol
Volume 37, Number 3, September 2005
Page(s) 265 - 271
DOI https://doi.org/10.1051/ject/200537265
Published online 15 September 2005
  1. Hirsh J Heparin. N Engl J Med. 1991;324:1565–74. [CrossRef] [PubMed] [Google Scholar]
  2. Levy JH, Pifarre R, Schaff HV, et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation. 1995;92:2236–44. [CrossRef] [PubMed] [Google Scholar]
  3. Lemmer JH, Stanford W, Bonney SL, et al. Aprotinin for coronary bypass operations-efficacy, safety, and influence on early saphenous vein graft patency—a multicenter, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg. 1994;107:543–53. [CrossRef] [Google Scholar]
  4. Stammers AH, Huffman S, Alonso A, et al. The anti-inflammatory effects of aprotinin in patients undergoing cardiac surgery with cardiopulmonary bypass. J Extra Corpor Technol. 1997;29:114–22. [CrossRef] [EDP Sciences] [Google Scholar]
  5. Wachtfogel YT, Kucich U, Hack CE, et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg. 1993;106:1–10. [CrossRef] [Google Scholar]
  6. Malviya S Monitoring and management of anticoagulation in children requiring extracorporeal circulation. Seminar Thromb Hemost. 1997;23:563–7. [CrossRef] [PubMed] [Google Scholar]
  7. Westaby S Aprotinin in perspective. Annals of Thoracic Surgery. 1993;55:1033–41. [CrossRef] [Google Scholar]
  8. Fritz H, Wunderer G Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung. 1983;33:479–94. [PubMed] [Google Scholar]
  9. Dietrich W, Spannagl M, Jochum M, et al. Influence of high-dose aprotinin treatment on blood loss and coagulation pattern in patients undergoing myocardial revascularization. Anesthesiology. 1990;73: 1119–26. [CrossRef] [PubMed] [Google Scholar]
  10. Ray MJ, Hales M, Marsh N Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass. Blood Coagul Fibrinolysis. 2001;12:129–35. [CrossRef] [PubMed] [Google Scholar]
  11. Bull BS Heparin therapy during extracorporeal circulation. J Thorac Cardiovasc Surg. 1975;69:123–33. [Google Scholar]
  12. Wang JS, Lin CY, Hung WT, Thisted RA, Karp RB In vitro effects of aprotinin on activated clotting time measured with different activators. J Thorac Cardiovasc Surg. 1992;104:1135–40. [CrossRef] [Google Scholar]
  13. Niles SD, Sutton RG, Ploessl J, Pennel B Correlation of ACT as measured with three commercially available devices with circulating heparin during cardiac surgery. J Extra Corpor Technol. 1995;27: 197–200. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Tian BS, Coffin S, Sutton R, Murray D, Olson J, Ploessl J The effect of hypothermia on heparin anticoagulation as measured by ACT and factor Xa inhibition. J Extra Corpor Technol. 1995;27:192–6. [CrossRef] [EDP Sciences] [Google Scholar]
  15. Lyman DJ The effect of chemical structure and surface properties of synthetic polymers on the coagulation of blood. Trans-Am Soc Artif Organs. 1973;20:474–9. [Google Scholar]
  16. Edmunds LH Extracorporeal circulation. Hemostasis and Thrombosis. Philadelphia: Lippincott; 1987:901–12 [Google Scholar]
  17. Valeri ED, Cassidy G, Khuri S, et al. Hypothermia induced reversible platelet dysfunction. Ann Surg. 1987;205:175–81. [CrossRef] [PubMed] [Google Scholar]
  18. Boldt J, Knothe C, Zickmann B, Bill S, Dapper F, Hempelmann G Platelet function in cardiac surgery: Influence of temperature and aprotinin. Ann Thorac Surg. 1993;55:652–8. [CrossRef] [Google Scholar]
  19. Birdi I, Izzat MB, Bryan AJ, Angelini GD Normothermic techniques during open heart surgery. Ann Thorac Surg. 1996;61:1573–80. [CrossRef] [Google Scholar]
  20. Kirklin JW, Barratt-Boyes BG Hypothermia, circulatory arrest, and cardiopulmonary bypass. Cardiac Surgery, 2nd ed. New York: Churchill Livingstone; 1993:61–127. [Google Scholar]
  21. Paul J, Cornillon B, Baguet G, Belleville J In vitro release of a heparin-like factor in dogs during profound hypothermia. J Thorac Cardiovasc Surg. 1981;82:45–8. [CrossRef] [Google Scholar]
  22. Huyzen RJ, Oeveren W, Feiyan W, Stellingwerf P, Boonstra PW, Gu Y In vitro effect of hemodilution on ACT and high-dose thrombin time during CPB. Ann Thorac Surg. 1996;62:533–7. [CrossRef] [Google Scholar]
  23. Herman E The effect of cold on platelets. Blood. 1971;38:39–48. [CrossRef] [PubMed] [Google Scholar]
  24. de Smet AAEA, Joen MCN, van Oeveren W, et al. Increased anti-coagulation during CPB by aprotinin. J Thorac Cardiovasc Surg. 1990;100:520–7. [CrossRef] [Google Scholar]
  25. Jones K, Nasrallah F, Darling E, et al. The in vitro effects of aprotinin on twelve different ACT tests. J Extra Corpor Technol. 2004; 3:51–7. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  26. Hunt BJ, Segal H, Yacoub M Aprotinin and heparin monitoring during CPB. Circulation. 1992;86:410–2. [Google Scholar]
  27. Heinmark RL, Kurachi K, Fujikawa K, Davie EW Surface activation of blood coagulation, fibrinolysis, and kinin formation. Nature. 1980;286:456–60. [CrossRef] [PubMed] [Google Scholar]
  28. Wang JS, Lin CY, Hung WT, Karp RB Monitoring of heparin-induced anticoagulation with kaolin-activated clotting time in cardiac surgical patients treated with aprotinin. Anesthesiology. 1992;77:1080–4. [CrossRef] [PubMed] [Google Scholar]
  29. Dietrich W, Jochum M Effect of celite and kaolin on activated clotting time in the presence of aprotinin: Activated clotting time is reduced by binding of aprotinin to kaolin. J Thorac Cardiovasc Surg. 1995;109:177–8. [CrossRef] [Google Scholar]
  30. Espana F Activation of Hageman Factor (FXII) by sulfatides and other agents in the absence of plasma proteases. J Lab Clin Med. 1983;102:31–45. [Google Scholar]
  31. Davies GC, Sobel M, Salzman EW Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass. Circulation. 1980;61:808–14. [CrossRef] [PubMed] [Google Scholar]
  32. Despotis GJ, Joist JH, Hogue CW, et al. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost. 1996;76:902–8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.